Title of article :
A Case Report of Three Guillain-Barré Syndrome during SARS-CoV-2Pandemic: Promising Outcome in a Patient with History of MultipleSclerosis
Author/Authors :
Ghahremani ، Amir ali Department of Neurology - School of Medicine - North Khorasan University of Medical Sciences , Bigdeli ، Amir Department of Nephrology - School of Medicine - North Khorasan University of Medical Sciences , Salarbashi ، Davoud Department of Nutrition and Food Sciences - Nanomedicine Research Center, School of Medicine - Gonabad University of Medical Sciences , Shakouri ، Pouyan Student Research Committee, School of Medicine - North Khorasan University of Medical Sciences , Elyasi ، Sepideh Department of Clinical Pharmacy - School of Pharmacy - Mashhad University of Medical Sciences
Abstract :
Neurologic complications in patients with coronavirus disease 19 (COVID-19) are common particularly in hospitalized patients. Guillain–Barré syndrome (GBS) is a rare complication of COVID-19. Most patients with GBS and COVID-19 presented with progressive, ascending limb weakness evolving over one to four days. There are some reported cases of GBS, mostly in form of case reports or case series, and also a comprehensive review on this topic. However, none of these cases experienced multiple sclerosis (MS) as an underlying disease. So, in this manuscript we reported three cases of COVID-19 induced GBS; one of them with history of MS and promising outcome after receiving five sessions of plasmapheresis and corticosteroid therapy
Keywords :
Guillain–Barré Syndrome , COVID , 19 , Multiple Sclerosis
Journal title :
Journal of Pharmaceutical Care
Journal title :
Journal of Pharmaceutical Care
